CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Repligen Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Repligen Corp
BUILDING 1, SUITE 100, 41 SEYON STREET
Phone: (781) 449-9560p:781 449-9560 WALTHAM, MA  02453  United States Ticker: RGENRGEN
Business Summary
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. The Company’s chromatography franchise includes a number of products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. The Company’s TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYes--Yes

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
8071 Medical laboratories
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairperson of the Board Karen A.Dawes 71 12/1/2011 9/15/2005
President, Chief Commercial Officer OlivierLoeillot 10/2/2023 10/2/2023
Chief Executive Officer, Director Tony J.Hunt 59 10/2/2023 5/5/2014
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Spectrum Laboratories, Inc. 18617 Broadwick Street Rancho Dominguez CA United States
TangenX Technology Corporation 910 Boston Turnpike Road Shrewsbury MA United States

Business Names
Business Name
ARTeSYN Biosolutions Holdings Ireland Ltd.
ARTeSYN Biosolutions Ireland Limited
ARTeSYN Biosolutions USA, LLC
25 additional Business Names available in full report.

General Information
Number of Employees: 1,783 (As of 12/31/2023)
Outstanding Shares: 55,838,548 (As of 3/18/2024)
Shareholders: 259
Stock Exchange: NASD
Federal Tax Id: 042729386
Fax Number: (302) 655-5049
Email Address: investors@repligen.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024